MRPL · Energy · 2026-08-21

Mangalore Refinery and Petrochemicals Ltd

Stage 1 · wk 3In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹176.8
+1.63% today
₹30,988 Cr · Large cap
About this companyEnergy· Oil & Gas - Refining & Marketing
Expand ▾

Mangalore Refinery and Petrochemicals Limited engages in the manufacture and sale of refined petroleum products in India. The company produces and sells bitumen, Xylol, high speed diesel, xylol, pet coke, sulphur, and motor gasoline, as well as polypropylene and other products. It also sells petrochemical products, such as aromatic products comprising paraxylene, benzene, heavy aromatics, paraffinic raffinate, reformate, and toluene. In addition, the company operates retail outlets. It also exports its products. Mangalore Refinery and Petrochemicals Limited was incorporated in 1988 and is based in Mangalore, India. Mangalore Refinery and Petrochemicals Limited is a subsidiary of Oil and Natural Gas Corporation Limited.

Visit company website →
P/E (TTM)
13.7
Forward 3.2
Earnings Growth (YoY)
-68.2%
Revenue -3.4%
ROE
+14.2%
Profit margin +2.2%
Dividend Yield
2.65%
P/B 2.0
vs 52W High
-14.5%
₹119.1 lo₹206.8 hi
14.5% below 52W high — pullback range
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 3
1w13w26w
Week 3 — early base, needs time
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
6.8%
200 DMA: ₹165.5 · rising
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.42x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↗
MA20 gently rising · +1.5% vs MA50 +4.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Energy
↑ Building
Stage 2%
35.7%
20d Δ
+7.1pp
1M return
+1.6%
3M return
-1.3%
Sector Stage-2 % · last 20 days
Sector has 9 Stage 2 leaders. See Energy Stage 2 →
Industry
Oil & Gas - Refining & Marketing
→ Flat
Stage 2%
25.0%
20d Δ
+0.0pp
1M return
+2.4%
3M return
-1.8%
Industry Stage-2 % · last 20 days
Industry has 2 Stage 2 leaders. See Oil & Gas - Refining & Marketing Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 50w
S4 29w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 1w → S2 50w → S3 13w → S2 2w → S3 3w → S4 29w → S1 12w → S2 4w → S3 2w → S4 8w → S1 1w → S2 11w → S3 4w → S2 12w → S3 8w → S4 5w → S1 3w current
Total tracked: 168 weeks across 17 stage runs.
1M
+0.5%
3M
+18.7%
6M
-2.9%
YTD
+25.2%
1Y
+44.7%
Scan Membership
Breakout Watch
Latest: 2026-02-13
4 appearances in last 60 days. First seen: 2024-08-21.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S1
Wk 3 · Vol —x
2026-08-20S1
Wk 3 · Vol —x
2026-08-19S1
Wk 3 · Vol —x
2026-08-18S1
Wk 3 · Vol —x
2026-08-17S1
Wk 3 · Vol —x
2026-08-14S1
Wk 2 · Vol —x
2026-08-13S1
Wk 2 · Vol —x
2026-08-12S1
Wk 2 · Vol —x
2026-08-11S1
Wk 2 · Vol —x
2026-08-10S1
Wk 2 · Vol —x
2026-08-07S1
Wk 1 · Vol —x
2026-08-06S1
Wk 1 · Vol —x
Sector Peers — Stage 2All →
ALPHAGEO
wk 1 · -5.9% from hi
8.8
DEEPINDS
wk 4 · -4.2% from hi
8.8
DOLPHIN
wk 1 · 0.0% from hi
8.7
ASIANENE
wk 11 · -3.0% from hi
8.5
CHENNPETRO
wk 23 · -3.2% from hi
7.4
Moving averages & range
50 DMA
₹164.1
200 DMA
₹165.5
52W High
₹206.8
52W Low
₹119.1
5D Low
₹174
Resistance levels (recent highs)
20d High
₹181.1
60d High
₹181.1
120d High
₹206.8
250d High
₹206.8
Next resistance
+2.4%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.